Demonstrates the synthesis and biological assessment of selective acetylcholinesterase inhibitors in neurodegenerative diseases, suggesting potential therapeutic options.
Acetylcholine (ACh), acetylcholinesterase enzyme (AChE), and AChE inhibition are of great importance in the treatment of neurodegenerative diseases. When it comes to AChE inhibition, FDA-approved AChE inhibitors such as Donepezil...
No takes yet. Share an insight, caveat, or question.
Kurban et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: